Cyclopharm Limited (ASX:CYC)

Market Cap	103.36M -54.2%
Revenue (ttm)	30.72M +37.6%
Net Income	-13.38M
EPS	-0.12
Shares Out	111.14M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,333
Average Volume	100,457
Open	0.9300
Previous Close	0.9300
Day's Range	0.9150 - 0.9400
52-Week Range	0.5600 - 2.3400
Beta	0.91
RSI	46.15
Earnings Date	Feb 25, 2026

About Cyclopharm

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1986
• Employees: 97
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CYC

Financial Performance

In 2024, Cyclopharm's revenue was 27.57 million, an increase of 4.68% compared to the previous year's 26.34 million. Losses were -13.20 million, 180.8% more than in 2023.